Lupus treatments: Anifrolumab, deucravacitinib deemed effective - Medical News Today
Share on Pinterest Two drugs have shown promise in the treatment of lupus in clinical trials. Image credit: luza studios/Getty Images. Lupus is an autoimmune disorder that causes a range of symptoms, some of which can be severe. It is more common in females, who account for 90% of cases. Once doctors confirm the diagnosis, they use treatments such as steroids to reduce inflammation, preventing organ damage and reducing flare-ups of symptoms. However, these treatments can have side effects, particularly with long-term use. Now, two drug trials have shown promising results for the treatment of lupus . In a long-term phase 3 trial, anifrolumab, an intravenous monoclonal antibody, and in a phase 2 trial, deucravacitinib, an oral treatment, emerged as both safe and effective. Autoimmune diseases occur when the body's immune system, which defends against disease, starts to attack healthy tissues. There are more than 80 known autoimmune diseases, which can affect almost any part of the b...